PortfoliosLab logoPortfoliosLab logo
CLS vs. ISRG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLS vs. ISRG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Celestica Inc. (CLS) and Intuitive Surgical, Inc. (ISRG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLS achieves a 32.99% return, which is significantly higher than ISRG's -27.42% return. Over the past 10 years, CLS has outperformed ISRG with an annualized return of 43.71%, while ISRG has yielded a comparatively lower 19.09% annualized return.


CLS

1D
1.88%
1M
9.64%
YTD
32.99%
6M
28.26%
1Y
213.67%
3Y*
207.28%
5Y*
116.26%
10Y*
43.71%

ISRG

1D
-0.45%
1M
-2.39%
YTD
-27.42%
6M
-24.20%
1Y
-19.74%
3Y*
9.23%
5Y*
7.37%
10Y*
19.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLS vs. ISRG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CLS
Celestica Inc.
32.99%220.27%215.23%159.80%1.26%37.92%-2.42%-5.70%-16.32%-11.56%
ISRG
Intuitive Surgical, Inc.
-27.42%8.51%54.72%27.14%-26.15%31.76%38.39%23.43%31.23%72.64%

Correlation

The correlation between CLS and ISRG is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.31

Correlation (5Y)
Calculated over the trailing 5-year period

0.35

Correlation (10Y)
Calculated over the trailing 10-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2000

0.28

The correlation between CLS and ISRG shifts across timeframes, from 0.12 (1 year) to 0.35 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CLS:

$45.48B

ISRG:

$147.90B

EPS

CLS:

$8.28

ISRG:

$8.24

PE Ratio

CLS:

47.45

ISRG:

49.88

PEG Ratio

CLS:

0.64

ISRG:

3.05

PS Ratio

CLS:

3.30

ISRG:

14.04

PB Ratio

CLS:

21.68

ISRG:

8.40

Total Revenue (TTM)

CLS:

$13.81B

ISRG:

$10.58B

Gross Profit (TTM)

CLS:

$1.60B

ISRG:

$7.02B

EBITDA (TTM)

CLS:

$1.32B

ISRG:

$3.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLS vs. ISRG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLS
CLS Risk / Return Rank: 9292
Overall Rank
CLS Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
CLS Sortino Ratio Rank: 8888
Sortino Ratio Rank
CLS Omega Ratio Rank: 8888
Omega Ratio Rank
CLS Calmar Ratio Rank: 9696
Calmar Ratio Rank
CLS Martin Ratio Rank: 9595
Martin Ratio Rank

ISRG
ISRG Risk / Return Rank: 1616
Overall Rank
ISRG Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
ISRG Sortino Ratio Rank: 1414
Sortino Ratio Rank
ISRG Omega Ratio Rank: 1616
Omega Ratio Rank
ISRG Calmar Ratio Rank: 2020
Calmar Ratio Rank
ISRG Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLS vs. ISRG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Celestica Inc. (CLS) and Intuitive Surgical, Inc. (ISRG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CLSISRGDifference
Sharpe ratioReturn per unit of total volatility

+3.43

Sortino ratioReturn per unit of downside risk

+3.67

Omega ratioGain probability vs. loss probability

1.37

0.90

+0.47

Calmar ratioReturn relative to maximum drawdown

6.91

-0.62

+7.53

Martin ratioReturn relative to average drawdown

16.83

-1.24

+18.07

CLS vs. ISRG - Sharpe Ratio Comparison

The current CLS Sharpe Ratio is 2.78, which is higher than the ISRG Sharpe Ratio of -0.65. The chart below compares the historical Sharpe Ratios of CLS and ISRG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CLS vs. ISRG - Drawdown Comparison

The maximum CLS drawdown since its inception was -96.93%, which is greater than ISRG's maximum drawdown of -82.26%. Use the drawdown chart below to compare losses from any high point for CLS and ISRG.


Loading charts...

Drawdown Indicators


CLSISRGDifference

Max Drawdown

Largest peak-to-trough decline

-96.93%

-82.26%

-14.67%

Max Drawdown (1Y)

Largest decline over 1 year

-29.24%

-32.14%

+2.90%

Max Drawdown (3Y)

Largest decline over 3 years

-53.96%

-34.10%

-19.86%

Max Drawdown (5Y)

Largest decline over 5 years

-53.96%

-49.90%

-4.06%

Max Drawdown (10Y)

Largest decline over 10 years

-80.60%

-49.90%

-30.70%

Current Drawdown

Current decline from peak

-16.78%

-32.66%

+15.88%

Average Drawdown

Average peak-to-trough decline

-73.31%

-21.28%

-52.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.98%

16.00%

-4.02%

Volatility

CLS vs. ISRG - Volatility Comparison

Celestica Inc. (CLS) has a higher volatility of 27.54% compared to Intuitive Surgical, Inc. (ISRG) at 9.70%. This indicates that CLS's price experiences larger fluctuations and is considered to be riskier than ISRG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLSISRGDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.54%

9.70%

+17.84%

Volatility (6M)

Calculated over the trailing 6-month period

55.42%

20.72%

+34.70%

Volatility (1Y)

Calculated over the trailing 1-year period

72.65%

30.69%

+41.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

57.70%

33.19%

+24.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.97%

32.40%

+17.57%

Dividends

CLS vs. ISRG - Dividend Comparison

Neither CLS nor ISRG has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CLS vs. ISRG - Financials Comparison

This section allows you to compare key financial metrics between Celestica Inc. and Intuitive Surgical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.50B2.00B2.50B3.00B3.50B4.00B20222023202420252026
4.05B
2.77B
(CLS) Total Revenue
(ISRG) Total Revenue
Values in USD except per share items

CLS vs. ISRG - Profitability Comparison

The chart below illustrates the profitability comparison between Celestica Inc. and Intuitive Surgical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
10.8%
66.1%
Portfolio components
CLS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.

ISRG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Intuitive Surgical, Inc. reported a gross profit of 1.83B and revenue of 2.77B. Therefore, the gross margin over that period was 66.1%.

CLS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported an operating income of 272.10M and revenue of 4.05B, resulting in an operating margin of 6.7%.

ISRG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Intuitive Surgical, Inc. reported an operating income of 855.30M and revenue of 2.77B, resulting in an operating margin of 30.9%.

CLS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.

ISRG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Intuitive Surgical, Inc. reported a net income of 821.50M and revenue of 2.77B, resulting in a net margin of 29.7%.


Frequently Asked Questions


CLS and ISRG have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLS has higher volatility (27.54%) compared to ISRG (9.70%). In terms of maximum drawdown, CLS dropped -96.93% vs ISRG's -82.26%.

CLS currently has the higher Sharpe Ratio (2.78 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLS and ISRG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer